Riyadh [Saudi Arabia], November 22 (ANI/Sputnik): The G20 countries have vowed to make efforts to ensure universal access to COVID-19 vaccines, therapeutics and diagnostics, a final statement adopted on Sunday after a two-day G20 summit said.
Moscow [Russia], November 22 (ANI): The price per dose of the Russian coronavirus vaccine Sputnik V will be much lower than that of the vaccines of US drug giants Pfizer and Moderna, said the Russian vaccine's official Twitter account on Sunday.
Riyadh [Saudi Arabia], November 21 (ANI): Russian President Vladimir Putin on Saturday at the G20 summit called the economic crisis caused by the ongoing COVID-19 pandemic 'a major world crisis' since the Great Depression.
Paris [France], November 21 (ANI/Sputnik): French President Emmanuel Macron told the G20 summit on Saturday that the world's leading economies should join efforts to create a system that envisions disturbing first doses of potential coronavirus vaccines to least developed countries.
Riyadh [Saudi Arabia], November 21 (ANI/Sputnik): The Saudi Arabian government has committed more than $500 million to funding efforts to develop and produce a safe and effective vaccine against the coronavirus disease, the country's health minister, Tawfig Al Rabiah, said ahead of the G20 S
New Delhi [India], November 20 (ANI): Prime Minister Narendra Modi on Friday held a meeting to review the country's vaccination strategy in which important issues related to progress of COVID-19 vaccine development, regulatory approvals and procurement were discussed.
Washington [US], November 20 (ANI): American drug giant Pfizer and German laboratory BioNTech on Friday said that they will be submitting to the US Food and Drug Administration for emergency use authorisation for their COVID-19 vaccine candidate.
Ambala (Haryana) [India], November 20 (ANI): Haryana Health Minister Anil Vij was administered a trial dose of Bharat Biotech's COVID-19 vaccine 'Covaxin' at a hospital in Ambala on Friday.
New Delhi [India], November 20 (ANI): As some of the coronavirus vaccine trials across the world are in their final stages, Indian airports and airlines have geared up to to handle the distribution of temperature-sensitive vaccines in the country.
New Delhi [India], November 19 (ANI): Major drug marker Serum of Institute of India (SII) on Thursday said that the coronavirus vaccine, developed by teams at the University of Oxford, has been shown to trigger a robust immune response in healthy adults aged 56-69 and those over 70 years
New Delhi [India], November 19 (ANI): In a major development, UK's Covid-19 vaccine has shown similar strong immune response in healthy older adults -aged 56 years and above- to those seen in people between 18 to 55 years, according to findings from a phase-2 trial.
New Delhi [India], November 19 (ANI): Union Health and Family Welfare Minister Dr Harsh Vardhan on Thursday said he was confident that COVID-19 vaccine would be ready in the next three-four months and added that the priority to provide the same to 135 crore Indians would be based on scientif